Literature DB >> 26851188

Colonoscopic screening shows increased early incidence and progression of adenomas in cystic fibrosis.

David E Niccum1, Joanne L Billings1, Jordan M Dunitz1, Alexander Khoruts2.   

Abstract

BACKGROUND: Colorectal cancer is an emerging problem in cystic fibrosis (CF). The goal of this study was to evaluate adenoma detection by systematic colonoscopic screening and surveillance.
METHODS: We analyzed prospectively collected results of colonoscopies initiated at age 40years from 88 CF patients at a single Cystic Fibrosis Center. We also reviewed results of diagnostic colonoscopies from 27 patients aged 30-39years performed during the same time period at the Center.
RESULTS: The incidence of polyp detection increased markedly after age 40 in CF patients. Greater than 50% were found to have adenomatous polyps; approximately 25% had advanced adenomas as defined by size and/or histopathology; 3% were found to have colon cancer. Multivariate analysis demonstrated specific risk factors for adenoma formation and progression.
CONCLUSIONS: Early screening and more frequent surveillance should be considered in patients with CF due to early incidence and progression of adenomas in this patient population.
Copyright © 2016 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenoma; Colon cancer; Colorectal cancer screening; Cystic fibrosis

Mesh:

Year:  2016        PMID: 26851188      PMCID: PMC5920645          DOI: 10.1016/j.jcf.2016.01.002

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  32 in total

1.  Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma.

Authors:  Toyoki Moribe; Norio Iizuka; Toshiaki Miura; Naoki Kimura; Shigeru Tamatsukuri; Hideo Ishitsuka; Yoshihiko Hamamoto; Kazuhiko Sakamoto; Takao Tamesa; Masaaki Oka
Journal:  Int J Cancer       Date:  2009-07-15       Impact factor: 7.396

2.  Screening for colorectal cancer: a guidance statement from the American College of Physicians.

Authors:  Amir Qaseem; Thomas D Denberg; Robert H Hopkins; Linda L Humphrey; Joel Levine; Donna E Sweet; Paul Shekelle
Journal:  Ann Intern Med       Date:  2012-03-06       Impact factor: 25.391

3.  Promoter hypermethylation of the CFTR gene and clinical/pathological features associated with non-small cell lung cancer.

Authors:  Ji Woong Son; Young Jin Kim; Hyun Min Cho; Soo Young Lee; Su Man Lee; Jae-Ku Kang; Jung Uee Lee; Yu Mi Lee; Sun Jung Kwon; Eugene Choi; Moon Jun Na; Jae Yong Park; Dong Sun Kim
Journal:  Respirology       Date:  2011-11       Impact factor: 6.424

4.  Long-term mortality after screening for colorectal cancer.

Authors:  Aasma Shaukat; Steven J Mongin; Mindy S Geisser; Frank A Lederle; John H Bond; Jack S Mandel; Timothy R Church
Journal:  N Engl J Med       Date:  2013-09-19       Impact factor: 91.245

5.  Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota.

Authors:  Susan V Lynch; Katherine C Goldfarb; Yvette K Wild; Weidong Kong; Robert C De Lisle; Eoin L Brodie
Journal:  Gut Microbes       Date:  2012-10-12

6.  A transposon-based genetic screen in mice identifies genes altered in colorectal cancer.

Authors:  Timothy K Starr; Raha Allaei; Kevin A T Silverstein; Rodney A Staggs; Aaron L Sarver; Tracy L Bergemann; Mihir Gupta; M Gerard O'Sullivan; Ilze Matise; Adam J Dupuy; Lara S Collier; Scott Powers; Ann L Oberg; Yan W Asmann; Stephen N Thibodeau; Lino Tessarollo; Neal G Copeland; Nancy A Jenkins; Robert T Cormier; David A Largaespada
Journal:  Science       Date:  2009-02-26       Impact factor: 47.728

7.  Disrupted interaction between CFTR and AF-6/afadin aggravates malignant phenotypes of colon cancer.

Authors:  Ting Ting Sun; Yan Wang; Hong Cheng; Hu Zhang Xiao; Juan Juan Xiang; Jie Ting Zhang; Siu Bun Sydney Yu; Tracey Amanda Martin; Lin Ye; Lai Ling Tsang; Wen Guo Jiang; Jiang Xiaohua; Hsiao Chang Chan
Journal:  Biochim Biophys Acta       Date:  2014-03

8.  Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.

Authors:  Thomas Flass; Suhong Tong; Daniel N Frank; Brandie D Wagner; Charles E Robertson; Cassandra Vogel Kotter; Ronald J Sokol; Edith Zemanick; Frank Accurso; Edward J Hoffenberg; Michael R Narkewicz
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 9.  Cystic fibrosis as a bowel cancer syndrome and the potential role of CK2.

Authors:  Anil Mehta
Journal:  Mol Cell Biochem       Date:  2008-07-05       Impact factor: 3.396

10.  Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.

Authors:  Serena Schippa; Valerio Iebba; Floriana Santangelo; Antonella Gagliardi; Riccardo Valerio De Biase; Antonella Stamato; Serenella Bertasi; Marco Lucarelli; Maria Pia Conte; Serena Quattrucci
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more
  16 in total

Review 1.  The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.

Authors:  Millie Garg; Chee Y Ooi
Journal:  Curr Gastroenterol Rep       Date:  2017-02

2.  Drosophila as a model for studying cystic fibrosis pathophysiology of the gastrointestinal system.

Authors:  Kevin Kim; Elizabeth A Lane; Aurelia Saftien; Haiyun Wang; Yue Xu; Frederik Wirtz-Peitz; Norbert Perrimon
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-28       Impact factor: 11.205

Review 3.  Luminal Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Samuel J Burton; Christine Hachem; James M Abraham
Journal:  Curr Gastroenterol Rep       Date:  2021-03-23

Review 4.  CFTR and Gastrointestinal Cancers: An Update.

Authors:  Rahul Bhattacharya; Zachary Blankenheim; Patricia M Scott; Robert T Cormier
Journal:  J Pers Med       Date:  2022-05-25

5.  Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.

Authors:  Andrea Gini; Ann G Zauber; Dayna R Cenin; Amir-Houshang Omidvari; Sarah E Hempstead; Aliza K Fink; Albert B Lowenfels; Iris Lansdorp-Vogelaar
Journal:  Gastroenterology       Date:  2017-11-02       Impact factor: 22.682

Review 6.  How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer.

Authors:  Christian Stock
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

7.  CFTR and the Regulation of Crypt Cell Proliferation.

Authors:  Deborah C Rubin
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-02-15

Review 8.  Cystic Fibrosis, CFTR, and Colorectal Cancer.

Authors:  Patricia Scott; Kyle Anderson; Mekhla Singhania; Robert Cormier
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

9.  A non-randomised single centre cohort study, comparing standard and modified bowel preparations, in adults with cystic fibrosis requiring colonoscopy.

Authors:  A G Matson; J P Bunting; A Kaul; D J Smith; J Stonestreet; K Herd; R S Hodgson; S C Bell
Journal:  BMC Gastroenterol       Date:  2019-06-13       Impact factor: 3.067

10.  Case report of synchronous post-lung transplant colon cancers in the era of colorectal cancer screening recommendations in cystic fibrosis: screening "too early" before it's too late.

Authors:  James M Abraham; Kathleen Mahan; Tetyana Mettler; Jordan M Dunitz; Alexander Khoruts
Journal:  BMC Gastroenterol       Date:  2019-07-29       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.